🔎 Trials Near Me

Beranda › Distrofi Otot Duchenne › Arkansas

Uji klinis Distrofi Otot Duchenne di Arkansas

7 studi untuk Distrofi Otot Duchenne mencari peserta di lokasi di Arkansas.

Kota di Arkansas

Teks studi resmi (Bahasa Inggris)

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

  • Arkansas Children's Hospital, Little Rock
Menerima pesertaFase 3
Usia 7 hingga 11 · Pria · Diperbarui 28 Sep 2026 · NCT07160634

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

  • Arkansas Children's Hospital, Little Rock
Menerima pesertaFase 1
Usia 2 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT04626674

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

  • Arkansas Children's Hospital, Little Rock
Menerima pesertaFase 1/2
Usia 0 hingga 17 · Pria · Diperbarui 8 Jul 2026 · NCT06138639

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

  • Arkansas Children's Research Institute, Little Rock
Menerima pesertaStudi observasional
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07127978

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

  • Arkansas Children's Hospital, Little Rock
Menerima pesertaFase 1/2
Usia 2 hingga 7 · Pria · Diperbarui 23 Jun 2026 · NCT07429240

Duchenne Electronic Health Record Study

  • Arkansas Children's Hospital, Little Rock
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT07609394

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

  • Arkansas Children's Hospital, Little Rock
Menerima pesertaFase 1/2
Usia 4 hingga 18 · Pria · Diperbarui 15 Des 2025 · NCT04906460

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.